American Association for Cancer Research
10780432ccr150314-sup-145156_2_supp_2991469_nxrx4t.png (1.59 MB)

Supplemental Figure S2 from Targeting Acidity in Pancreatic Adenocarcinoma: Multispectral Optoacoustic Tomography Detects pH-Low Insertion Peptide Probes In Vivo

Download (1.59 MB)
posted on 2023-03-31, 19:05 authored by Charles W. Kimbrough, Anil Khanal, Matthew Zeiderman, Bigya R. Khanal, Neal C. Burton, Kelly M. McMasters, Selwyn M. Vickers, William E. Grizzle, Lacey R. McNally

Supplemental Figure S2: As the K7-750 probe did not bind to pancreas tumors, deoxy-hemoglobin signal was utilized to denote the location of the pancreas tumors. Orthogonal views of deoxy-hemoglobin signal indicate the location of the pancreatic tumor bed in both S2VP10 and S2013 xenografts. (A) Orthogonal view of deoxy-hemoglobin signal indicating the S2VP10 tumor within the mouse. Mouse shown is the same mouse shown as injected with V7-750 probe in Figure 3. MSOT images of this mouse are also available as a movie clip (Supplement Figure S5). (B) Orthogonal view of deoxy-hemoglobin signal indicating the S2VP10 tumor within the mouse that was injected with K7-750 (mouse shown from Figure 3).



Background: pH-low insertion peptides (pHLIP) can serve as a targeting moiety that enables pH-sensitive probes to detect solid tumors. Using these probes in conjunction with multispectral optoacoustic tomography (MSOT) is a promising approach to improve imaging for pancreatic cancer.Methods: A pH-sensitive pHLIP (V7) was conjugated to 750 NIR fluorescent dye and evaluated as a targeted probe for pancreatic adenocarcinoma. The pH-insensitive K7 pHLIP served as an untargeted control. Probe binding was assessed in vitro at pH 7.4, 6.8, and 6.6 using human pancreatic cell lines S2VP10 and S2013. Using MSOT, semiquantitative probe accumulation was then assessed in vivo with a murine orthotopic pancreatic adenocarcinoma model.Results: In vitro, the V7-750 probe demonstrated significantly higher fluorescence at pH 6.6 compared with pH 7.4 (S2VP10, P = 0.0119; S2013, P = 0.0160), whereas no difference was observed with the K7-750 control (S2VP10, P = 0.8783; S2013, P = 0.921). In the in vivo S2VP10 model, V7-750 probe resulted in 782.5 MSOT a.u. signal compared with 5.3 MSOT a.u. in K7-750 control in tumor (P = 0.0001). Similarly, V7-750 probe signal was 578.3 MSOT a.u. in the S2013 model compared with K7-750 signal at 5.1 MSOT a.u. (P = 0.0005). There was minimal off-target accumulation of the V7-750 probe within the liver or kidney, and probe distribution was confirmed with ex vivo imaging.Conclusions: Compared with pH-insensitive controls, V7-750 pH-sensitive probe specifically targets pancreatic adenocarcinoma and has minimal off-target accumulation. The noninvasive detection of pH-targeted probes by means of MSOT represents a promising modality to improve the detection and monitoring of pancreatic cancer. Clin Cancer Res; 21(20); 4576–85. ©2015 AACR.See related commentary by Reshetnyak, p. 4502

Usage metrics

    Clinical Cancer Research



    Ref. manager